Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Dapagliflozin Compared to Pioglitazone in Diabetic and Non-diabetic Patients with Non-alcoholic Steatohepatitis

NCT05254626 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT05254626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05254626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Dapagliflozin Compared to Pioglitazone in Diabetic and Non-diabetic Patients with Non-alcoholic Steatohepatitis
Lead sponsor
Cairo University
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2022
Completion date
July 23, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis